Application 204960
- Type
- ANDA
- Sponsor
- JIANGSU HENGRUI MED
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 2MG BASE/ML | No | No |
| 002 | CISATRACURIUM BESYLATE PRESERVATIVE FREE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 10MG BASE/ML | No | No |
| 003 | CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 2MG BASE/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2033 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 0703-2045 | Cisatracurium Besylate | Cisatracurium Besylate | Teva Parenteral Medicines, Inc. | ANDA | Current |
| 57884-3061 | CISATRACURIUM BESYLATE | Cisatracurium besylate | Jiangsu Hengrui Medicine Co., Ltd. | ANDA | Current |
| 57884-3063 | CISATRACURIUM BESYLATE | Cisatracurium besylate | Jiangsu Hengrui Medicine Co., Ltd. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 47056 | ORIG | 2017-01-31 |